NEWS

Stay informed about the latest NEWS from SOCIUM.

2025-04-21	Results of Joint Research on Drug Development with Nanjing Medical University Published in a Leading International Journal
2025-04-15	The application of a drug candidate for ALS treatment was issued as a patent
2025-02-12	A paper on our phosphorylation analysis service was published in a leading international academic journal
2024-12-23	Our Phosphorylation Analysis Service to Expand in the U.S.
2024-09-17	SOCIUM Inc. and Huaxi Hospital of Sichuan University have decided to conduct an investigator-initiated clinical trial of SO-002, a drug candidate for the treatment of amyotrophic lateral sclerosis (ALS)
2024-06-07	AI drug discovery venture that takes on the challenge of overcoming “unmet medical needs, SOCIUM Inc.’s paper was published in The Journal of Biomedical Research
2024-06-05	株式投資型クラウドファンディングの実施 及び オンライン事業説明会開催のお知らせ
2024-01-11	Announcement of a Strategic Alliance for the Development of Drugs for the Treatment of Rare Diseases in China
2023-10-03	Our Paper on Phosphorylation Analysis Accepted through Collaboration with Nanjing Medical University School of Pharmacy (China)
2023-09-19	Exhibit at “Japan Healthcare Venture Summit 2023”